osimertinib
astrazeneca
['adaura', 'sclc', 'lung', 'osimertinib', 'nsclc', 'aura ,(-laura)']
asco 2023: the discuss adaura trial findings of osimertinib for egfr-mutated nsclc #lungcancer #asco2023 
DocWire News delivers the most relevant medical news to over 1M HCPs daily.